Home / News and Updates / The Employee Profile in China Pharma R&D

The Employee Profile in China Pharma R&D

Source: Appliedclinicaltrialsonline.com

Pharmaceutical companies are currently targeting the emerging markets of China and Africa for their future expansion, with the highest investment - USD 5.32 billion - just in China alone. Around 29 plants with a combination of manufacturing, production units and research & development centers are scheduled to open through the 2015 to 2022 period across regions. In addition to new facilities, approximately five brownfield expansions and nine closures are also scheduled within the same period. Figure 1 shows the various expansions vs. closures regionally planned by the top 10 big pharma companies

Get Ahead with AI-Enabled Market Insights Schedule a Demo Now

Schedule a Demo Now